VolitionRx Limited to Present at Conferences in the U.S. Next Week
VolitionRx Limited Announces Full Fiscal Year 2018 Financial Results and Business Update
VolitionRx Limited Schedules Full Year 2018 Earnings Conference Call and Business Update
VolitionRx Limited Announces Third Quarter 2018 Financial Results and Business Update
VolitionRx Limited Schedules Third Quarter 2018 Earnings Conference Call and Business Update
VolitionRx Limited to Expand its Nu.Q(TM) Trials to Veterinary Diagnostics
VolitionRx Limited Releases Video Featuring Interviews with its Scientific Advisory Board
VolitionRx Limited to Attend Multiple Conferences in September
VolitionRx Limited Announces Second Quarter 2018 Financial Results and Business Update
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer
